Cigna Corp vs Rocket Lab USA Inc — how do they compare? Cigna Corp trades at $273 (market cap $73.56B), while Rocket Lab USA Inc trades at $80.47 (market cap $50.01B). The key difference: Cigna Corp is the larger of the two by market cap, and Cigna Corp pays a 2.24% dividend while Rocket Lab USA Inc pays none. Which is the better fit depends on your goals.
| CI | RKLB | |
|---|---|---|
Market Cap | $73.56B | $50.01B |
Sector | Health | Technology |
52-Week High | $311.00 | $150.23 |
52-Week Low | $244.41 | $39.48 |
Enterprise Value | $98.27B | $47.84B |
Dividend Yield | 2.24% | — |
Trailing returns across standard periods
Latest headlines on both assets
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →Rocket Lab USA, Inc. is an aerospace manufacturer and small-satellite launch service provider. The company specializes in developing rockets for orbital launch, including its flagship *Electron* vehicle, and is developing the next-generation, reusable *Neutron* rocket. Beyond launch services, Rocket Lab also offers satellite design, manufacturing, and spacecraft component solutions, positioning itself as an end-to-end provider for the space industry.
Read more on RKLB →